FOP Publications From Last 5 Years

Research Publications, Peer-reviewed:

  1. Kaplan, F., J. Sawyer, S. Connors, K. Keough, E. Shore, F. Gannon, D. Glaser, D. Rocke, M. Zasloff, and J. Folkman (1998). Urinary basic fibroblast growth factor: A biochemical marker and potential therapeutic target for pre-osseous fibroproliferative lesions in patients who have fibrodysplasia ossificans progressiva. Clin. Ortho. Rel. Res. 346, 59-65.
  2. Gannon, F.H., B.A. Valentine, E.M. Shore, M.A. Zasloff, and F.S. Kaplan (1998). Acute lymphocytic infiltration in an extremely early lesion of fibrodysplasia ossificans progressiva. Clin. Ortho. Rel. Res. 346, 19-25.
  3. Olmsted, E.A., F.H. Gannon, Z-Q. Wang, A.E. Grigoriadis, E.F. Wagner, M.A. Zasloff, E.M. Shore, and F.S. Kaplan (1998). Embryonic over-expression of the c-fos proto-oncogene: A murine stem cell chimera applicable to the study of fibrodysplasia ossificans progressiva in humans. Clin. Ortho. Rel. Res. 346, 81-94.
  4. Lanchoney, T.F., E.A. Olmsted, E.M. Shore, F.A. Gannon, V. Rosen, M.A. Zasloff, and F.S. Kaplan (1998). Characterization of bone morphogenetic protein-4 receptors in fibrodysplasia ossificans progressiva. Clin. Ortho. Rel. Res. 346, 38-45.
  5. Calvert, G.C. and E.M. Shore (1998). The HLA-B27 allele is not correlated with fibrodysplasia ossificans progressiva. Clin. Ortho. Rel. Res. 346, 66-70.
  6. Xu, M-q. and E.M. Shore (1998). Mutational screening of the bone morphogenetic protein-4 gene in a family with fibrodysplasia ossificans progressiva. Clin. Ortho. Rel. Res. 346, 53-58.
  7. Shore, E.M., M-q. Xu, P.B. Shah, H.B. Janoff, G.V. Hahn, M.A. Deardorff, L. Sovinsky, N.B. Spinner, M.A. Zasloff, J.M. Wozney, and F.S. Kaplan (1998). The human bone morphogenetic protein 4 (BMP-4) gene: Molecular structure and transcriptional regulation. Calcif. Tissue Intl. 63, 221-229.
  8. Kaplan, F.S., and E.M. Shore (1998). The Encrypted Morphogens of Skeletogenesis: Biological Errors and Pharmacologic Potentials. Biochemical Pharmacology 55,373-382.
  9. Pignolo, R.J., Martin, B.G., Horton, J.H., Kalbach, A.N., and Cristofalo, V.J. 1998. WI-38 Cells Arrest in Late G1 and are Unable to Traverse the Cell Cycle from a True G0 State. Exp. Gerontology 33: 67-80.
  10. Pignolo, R.J., Rotenberg, M.O., Horton, J.H., and Cristofalo, V.J. 1998. Senescent WI-38 Fibroblasts Overexpress LPC-1, a Putative Transmembrane Shock Protein. Exp. Cell Res. 240: 305-311.
  11. Cristofalo, V.J., Allen, R.G., Pignolo, R.J., Martin, B.G. and Beck, J.C. 1998. Relationship Between Donor Age and the Replicative Lifespan of Human Cells in Culture: A Re-Evaluation. Proc. Natl. Acad. Sci. 95: 10614-10619.
  12. Shafritz AB, Kaplan FS. Differential expression of bone and cartilage related genes in fibrodysplasia ossificans progressiva, myositis ossificans traumatica, and osteogenic sarcoma. Clin Orthop Rel Res 346:46-52, 1998.
  13. Kussmaul, WG, Esmail AN, Sagar Y, Ross J, Gregory S, Kaplan FS. Clin Orthop Rel Res 346:59-65, 1998. Pulmonary and cardiac function in advanced fibrodysplasia ossificans progressiva. Clin Orthop and Rel Res 346:104-109, 1998
  14. Glaser DL, Rocke DM, Kaplan FS. Catastrophic falls in patients who have fibrodysplasia ossificans progressiva. Clin Orthop Rel Res 346:110-116, 1998
  15. Urtizberea JA, Testart H, Cartault F, Boccon-Gibod L, LeMerrer M, Kaplan FS. Progressive osseous heteroplasia J Bone Joint Surg 80B: 768-771, 1998
  16. Virdi, A.S., E.M. Shore, R.O.C. Oreffo, M. Li, J.M. Connor, R. Smith, F.S. Kaplan, and J.T. Triffit (1999). Phenotypic and molecular heterogeneity in fibrodysplasia ossificans progressiva. Calcified Tissue Intl. 65, 250-255.
  17. Tresini, M., Pignolo, R.J., Allen, R.G., and Cristofalo, V.J. 1999. Effects of Donor Age on the Expression of a Marker of Replicative Senescence (EPC-1) in Human Dermal Fibroblasts. J. Cell. Physiol. 179: 11-17.
  18. Feldman, G., M. Li, S. Martin, M. Urbanek, J.A. Urtizberea, M. LeMerrer, J.M. Connor, J. Triffitt, R. Smith, M. Muenke, F.S. Kaplan, E.M. Shore (2000). Fibrodysplasia ossificans progressiva, a disorder of severe heterotopic ossification maps to human chromosome 4q27-31. Amer. J. Hum. Genet.66, 128-135.
  19. Xu, M-q., G. Feldman, M. LeMerrer, Y. Yao Shugart, D.L. Glaser, J.A. Urtizberea, M. Fardeau, J.M. Connor, J. Triffitt, R. Smith, E.M. Shore, F.S. Kaplan (2000). Linkage exclusion and mutational analysis of the noggin gene in patients with fibrodysplasia ossificans progressiva (FOP). Clinical Genetics 58, 291-298.
  20. Yeh, G., S. Mathur, A. Wivel, M. Li, E.A. Olmsted, F.H. Gannon, A. Ulied, L. Audi, and E.M. Shore (2000). GNAS1 mutation and Cbfa1 misexpression in a child with severe congenital plate-like osteoma cutis. J. Bone Min. Res. 15, 2063-2073.
  21. Eddy, M.C., S.M. Jan de Beur, S.M. Yandow, W.H. McAlister, E.M. Shore, C. d'Amato, C.H. Meyers-Seifert, F.S. Kaplan, M.P. Whyte, and M.A. Levine (2000). Deficiency of the ?-subunit of the stimulatory G protein and severe extraskeletal ossification. J. Bone Min. Res. 15, 2074-2083.
  22. Kaplan FS, Shore EM. Progressive Osseous Heteroplasia. J Bone Min Res 15:2084-2094, 2000
  23. Mahboubi S., D.L. Glaser, E.M. Shore, and F.S. Kaplan (2001). Fibrodysplasia ossificans progressiva. Pediatric Radiology 31(5), 307-314.
  24. Gannon, F.H., D. Glaser, R. Caron, L.D.R. Thompson, E.M. Shore, and F.S. Kaplan (2001). Mast cell involvement in fibrodysplasia ossificans progressiva. Human Pathology 32(8), 842-848.
  25. Emerson SG, Kaplan FS. Answer: marrow stem cell transplantation in fibrodysplasia ossificans progressiva. Clin Orthop Rel Res 392: 451-455, 2001
  26. Shore, E.M., J. Ahn, S.M. Jan de Beur, M. Li, M. Xu, R.J. McKinlay Gardner, M.A. Zasloff, M.P. Whyte, M.A. Levine, and F.S. Kaplan (2002). Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia (POH). N. Engl. J. Med. 346, 99-106.
  27. Watts JA, Morley M, Burdick JT, Fiori JL, Ewens WJ, Spielman RS, Cheung VG. Gene expression phenotype in heterozygous carriers of ataxia telangiectasia. American Journal of Human Genetics 2002 Oct;71(4):791-800.
  28. Ahn, J., G. Feldman, L. Terry, E.M. Shore, F.S. Kaplan (2003). Exoneration of NF-kB dysregulation in fibrodysplasia ossificans progressiva. Clin. Orthop. Rel. Res. 406, 205-213.
  29. Olmsted, E.A., F.S. Kaplan, and E.M. Shore (2003). Bone morphogenetic protein 4 regulation in fibrodysplasia ossificans progressiva. Clin. Ortho. Rel. Res. 408, 331-343.
  30. Faust, R.A., E.M. Shore, C.E. Stevens, M. Xu, S. Shah, C.D. Phillips, and F.S. Kaplan (2003). Progressive osseous heteroplasia in the face of a child. Amer. J. Med. Genet. 118A, 71-75.
  31. Pignolo, R.J., Francis, M.K., Rotenberg, M.O. and Cristofalo, V.J. 2003. A Putative Role for EPC-1/PEDF in the G0 Growth Arrest of Human Fibroblasts. J. Cell. Physiol 195:12-20.
  32. Sullivan DT, MacIntyre R, Fuda N, Fiori JL, Barrilla J, Ramizel L. Analysis of glycolytic enzyme co-localization in Drosophila flight muscle. Journal of Experimental Biology 2003 Jun;206(Pt12):2031-8.
  33. Ahn, J., L. Serrano de la Pena. E.M. Shore and F.S. Kaplan (2003). Paresis of a bone morphogenetic protein antagonist response in a genetic disorder of heterotopic skeletogenesis. J. Bone Joint Surg. in press.
  34. Hegyi, L., Gannon F.H., Glaser D.L., Shore E.M., Kaplan F.S., Shanahan C.M. (2003) Stromal cells of fibrodysplasia ossificans progressiva lesions express smooth muscle lineage markers and the osteogenic transcription factor Runx2/Cbfa-1: Clues to a vascular origin of heterotopic ossification? J. Pathology. in press.
  35. Economides, A.N., D.L. Glaser, L. Wang, X. Liu, R. Kimble, J. P. Fandl, J.M. Wilson, N. Stahl, F.S. Kaplan, E.M. Shore (2002). In Vivo Somatic Cell Gene Transfer of an Engineered Noggin Mutein Prevents BMP4-Induced Heterotopic Ossification in the Mouse. JBJS accepted.

Research Publications, non-peer reviewed

  1. Kaplan, F.S. and E.M. Shore (1998). The seventh annual report of the fibrodysplasia ossificans progressiva (FOP) collaborative research project. The FOP Connection 11(1),12-18.
  2. Kaplan, F.S. and E.M. Shore (1998). The second annual report of the progressive osseous heteroplasia (POH) collaborative research project. V. 2: 1-13.
  3. Kaplan, F.S., D.M. Glaser, F.H. Gannon, and E.M. Shore (1998). The molecules of immobility: Searching for the skeleton key. Univ. of Penn. Orthopaedic J. 11, 59-66.
  4. Kaplan, F.S. and E.M. Shore (1998). In search of a cure. The FOP Connection 11(3),1-2.
  5. Kaplan, F.S. and E.M. Shore (1999). The eighth annual report of the fibrodysplasia ossificans progressiva (FOP) collaborative research project. The FOP Connection 12(2),12-24.
  6. Kaplan, F.S. and E.M. Shore (1999). The third annual report of the progressive osseous heteroplasia (POH) collaborative research project. V.3: 1-9.
  7. Kaplan, F.S. and E.M. Shore (1999). Research breakthroughs in fibrodysplasia ossificans progressiva. The FOP Connection 12(4), 23.
  8. Kaplan, F.S. and E.M. Shore (2000). The ninth annual report of the fibrodysplasia ossificans progressiva (FOP) collaborative research project. The FOP Connection 13(2), 16-28.
  9. Shore, E.M. and F.S. Kaplan (2000). The fourth annual report of the progressive osseous heteroplasia (POH) collaborative research project.
  10. Kaplan, F.S. and E.M. Shore (2001). The tenth annual report of the fibrodysplasia ossificans progressiva (FOP) collaborative research project. The FOP Connection 14(2), 16-31.
  11. Shore, E.M. and F.S. Kaplan (2001). Five-year report of the progressive osseous heteroplasia (POH) collaborative research project.
  12. Kaplan, F.S., D.L. Glaser, and E.M. Shore (2002). The eleventh annual report of the fibrodysplasia ossificans progressiva (FOP) collaborative research project. The FOP Connection 15(2), 1-17.
  13. Shore, E.M. and F.S. Kaplan (2002). The 2002 annual report of the progressive osseous heteroplasia (POH) collaborative research project.
  14. Kaplan, F.S., D.L. Glaser, and E.M. Shore (2003). The twelfth annual report of the fibrodysplasia ossificans progressiva (FOP) collaborative research project. The FOP Connection in press.

Abstracts:

  1. 1. Gannon, F.H., D. Glaser, R. Caron, L.D.R. Thompson, E.M. Shore, and F.S. Kaplan (2000). Mast cell involvement in fibrodysplasia ossificans progressiva. J. Bone Min. Res. 15 (Suppl 1), S210. (Presented at the American Society for Bone and Mineral Research Annual Meeting; Toronto, Canada, September 2000.)
  2. Xu, M-q., G. Feldman, M. LeMerrer, Y.Y. Shugart, D.L. Glaser, J.A. Urtizberea, M. Fardeau, J.M. Connor, J. Triffitt, R. Smith, E.M. Shore, F.S. Kaplan (2000). Linkage exclusion and mutational analysis of the noggin gene in patients with fibrodysplasia ossificans progressiva (FOP). J. Bone Min. Res. 15 (Suppl 1), S213. (Presented at the American Society for Bone and Mineral Research Annual Meeting; Toronto, Canada, September 2000.)
  3. Serrano de la Pena L., P.C. Billings, J. Ahn, F.S. Kaplan, and E.M. Shore (2001). Dysregulation of BMP receptor IA in fibrodysplasia ossificans progressiva. J. Bone Min. Res. 16 (Suppl 1), S320. (Presented at the First Annual University of Pennsylvania Flow Cytometry Forum - PennFlow 2001; Philadelphia, PA, October 10, 2001.
  4. Ahn, J., L. Serrano de la Pena, E.M. Shore, and F.S. Kaplan (2001). Paresis of a BMP4 antagonist response in fibrodysplasia ossificans progressiva. J. Bone Min. Res. 16 (Suppl 1), S157. (Presented at the American Society for Bone and Mineral Research Annual Meeting; Phoenix, AZ, October 2001.)
  5. Serrano de la Pena L., P.C. Billings, J. Ahn, F.S. Kaplan, and E.M. Shore (2001). Dysregulation of BMP receptor IA in fibrodysplasia ossificans progressiva. J. Bone Min. Res. 16 (Suppl 1), S320. (Presented at the American Society for Bone and Mineral Research Annual Meeting; Phoenix, AZ, October 2001.)
  6. Wu Y., P.C. Billings, R. Patel, E.M. Shore, and F.S. Kaplan (2001). MMP-2 and MMP-9 activity in fibrodysplasia ossificans progressiva. J. Bone Min. Res. 16 (Suppl 1), S452. (Presented at the American Society for Bone and Mineral Research Annual Meeting; Phoenix, AZ, October 2001.)
  7. Scarlett R., E.M. Shore, and F.S. Kaplan (2001). Flare-ups of fibrodysplasia ossificans progressiva associated with influenza B infections: A report of a family. J. Bone Min. Res. 16 (Suppl 1), S559. (Presented at the American Society for Bone and Mineral Research Annual Meeting; Phoenix, AZ, October 2001.)
  8. Gillessen-Kaesbach G.G., C. Grunberg, E.M. Shore, G. Feldman, F.S. Kaplan (2001). A clinical and molecular study of 20 German patients with fibrodysplasia ossificans progressiva. Amer. J. Hum. Genet. 69 (4) (Suppl.), 298. (Presented at the American Society of Human Genetics Annual Meeting; San Diego, CA, October 2001.)
  9. Glaser D.L., F.S. Kaplan, L. Wang, A.N. Economides. J.M. Wilson, N. Stahl, E.M. Shore (2002). Noggin gene therapy for the prevention of BMP induced heterotopic ossification in the mouse: Implications for the treatment of fibrodysplasia ossificans progressiva and other disorders of ectopic ossification in humans. (Presented at the Orthopaedic Research Society Annual Meeting, February 2002.)
  10. Kaplan, F.S., J. Ahn, L. Serrano de la Pena, E.M. Shore (2002). Fibrodysplasia ossificans progressiva: Clues to the formation of a heterotopic skeleton. Calcif. Tissue Int. 70, 243. (Presented at 29th European Symposium on Calcified Tissues; Zagreb, Croatia, May 2002.)
  11. Glaser D.L., E.M. Shore, L. Wang, A.N. Economides, J.M. Wilson, N. Stahl, F.S. Kaplan (2002). In Vivo Somatic Cell Gene Transfer of an Engineered Noggin Mutein Prevents BMP4-Induced Heterotopic Ossification in the Mouse: Implications for the Treatment of Fibrodysplasia Ossificans Progressiva and Other Disorders of Heterotopic Ossification in Humans. (Presented at the American Society of Gene Therapy 5th Annual Meeting, June 2002.)
  12. Billings P.C., Y. Wu, R. Caron, L. Serrano de la Pena, F.H. Gannon, B. Young, M. Pacifici, F.S. Kaplan, E.M. Shore (2002). Lymphocytes from FOP patients induce early FOP-like lesions in nude mice. (Presented at the American Society for Bone and Mineral Research Annual Meeting; San Antonio, TX, September 2002.)
  13. Xu, M., S.M. Jan de Beur, C. Li, N. Hebela, S. Fitzgerald. M.A. Levine, F.S. Kaplan, E.M. Shore (2002). Expression of mRNA and protein for the stimulatory G protein alpha subunit (Gsa) of adenylyl cyclase in progressive osseous heteroplasia (POH) patients with inactivating GNAS1 mutations. (Presented at the American Society for Bone and Mineral Research Annual Meeting; San Antonio, TX, September 2002.)
  14. Serrano de la Pena, L., P.C. Billings, E.M. Shore, F.S. Kaplan (2002). Dysregulated BMP4 signaling in FOP lymphocytes. (Presented at the American Society for Bone and Mineral Research Annual Meeting; San Antonio, TX, September 2002.)
  15. Davis, A., E. Olmsted-Davis, Z. Gugala, K. Moran, R. Lindsey, E. Shore, F. Kaplan, F. Gannon (2002). Mechanisms of BMP2-induced heterotopic bone formation. (Presented at the American Society for Bone and Mineral Research Annual Meeting; San Antonio, TX, September 2002.)
  16. Feldman, G.J., R. Patel, P.C. Billings, D.M. Kingsley, E.M. Shore, F.S. Kaplan (2002). Dysregulated expression of BMP5 in a patient with deformed helices, axial skeletal defects, and heterotopic ossification: A clue from the short-ear mouse. (Presented at the American Society for Bone and Mineral Research Annual Meeting; San Antonio, TX, September 2002.)
  17. Shore, E.M., J. Ahn, L. Serrano de la Pena, F.S. Kaplan. BMP signaling in fibrodysplasia ossificans progressiva. (Presented at the International BMP Conference 2002; Sacramento, CA; October 2002.)
  18. Kaplan, F.S., L. Serrano de la Pena, J. Ahn, P. Billings, E.M. Shore. MHS: Multiple hereditary skeletons - an endochondral conundrum. (Presented at the University of Arizona Health Science Center-NIH Conference on Multiple Hereditary Exoxtosis; Tuscon, AZ, October 2002.)
  19. Glaser D.L., R. Ramachandran, E.M. Shore, T. Lin, P. Yeh, P. Beredjiklian, F.S. Kaplan, D.J. Goldhamer, L.J. Soslowsky. The origin of cells within a healing tendon. (Presented at the Orthopaedic Research Society Annual Meeting, New Orleans, LA; February 2003; Finalist for ORS New Investigator Recognition Award for DLG.)
  20. Goldhamer, D.J., R. Ramachandran, D.L. Glaser, E. So, E.M. Shore, F.S. Kaplan. Identification of osteogenic progenitor cells in skeletal muscle. (Presented at the Orthopaedic Research Society Annual Meeting, New Orleans, LA; February 2003.)
  21. Roach, H.I., R.S. Tare, R.O.C. Oreffo, E.M. Shore, and F.S. Kaplan. Inhibition of BMP-mediated osteoinduction by pleiotrophin: possible relevance to fibrodysplasia ossificans progressiva. (Presented at the 30th European Symposium on Calcified Tissue, Rome, Italy; May 2003.)
  22. Pignolo, R.J., F. S. Kaplan, and E. M. Shore. The GNAS1 gene as a regulator of osteoblast differentiation and molecular target for the stimulation of bone formation. (Submitted to the American Geriatric Society Annual Meeting, Baltimore, MD; May 2003.)
  23. Nader, H., E. M. Shore, and F. S. Kaplan. A study of identical twins with Fibrodysplasia ossificans progressiva (FOP): The role of environment in the progression of heterotopic ossification. (Submitted to the American Society for Bone and Mineral Research Annual Meeting; Minneapolis, MN; September 2003.)
  24. Billings, P., L. Serrano de la Pena, J. L. Fiori, R. Caron, E. M. Shore, and F. S. Kaplan. Defective BMP receptor internalization in fibrodysplasia ossificans progressiva. (Submitted to the American Society for Bone and Mineral Research Annual Meeting; Minneapolis, MN; September 2003.)
  25. Glaser, D. L., R. Ramachandran, X. Jiao, T. W. Lin, L. J. Soslowsky, E. M. Shore, F. S. Kaplan, and D. J. Goldhamer. The heritage of cells within postnatal tendon and bone formation. (Submitted to the American Society for Bone and Mineral Research Annual Meeting; Minneapolis, MN; September 2003.)
  26. Glaser, D. L., A. N. Economides, L. Wang, K. V. Sachs, N. Stahl, J. M. Wilson, F. S. Kaplan, and E. M. Shore. Durable adeno-associated virus delivery of a systemic noggin mutein prevents BMP induced heterotopic ossification. (Submitted to the American Society for Bone and Mineral Research Annual Meeting; Minneapolis, MN; September 2003.)
  27. Pignolo, R. J., S. Blythe, J. Gilmore, F. S. Kaplan, and E. M. Shore. Differential osteogenic potential in bone marrow and soft tissue stromal cells mediated by the Gnas/GNAS1 gene. (Submitted to the American Society for Bone and Mineral Research Annual Meeting; Minneapolis, MN; September 2003.)

Editorials, Reviews, Chapters:

  1. Kaplan, F.S., E.M. Shore, F.H. Gannon, M.A. Zasloff (1998). The candidate gene approach to a rare genetic disease of skeletal malformations and ectopic osteogenesis in humans. In: Skeletal Growth and Development, J.A. Buckwalter, M.G. Ehrlich, L.J. Sandell, S.B. Trippet, Editors. American Academy of Orthopaedic Surgeons, Rosemont, IL. pp. 435-447.
  2. Kaplan, F.S., M. Delatycki, F.H. Gannon, J.G. Rogers, R. Smith, E.M. Shore (1998). Fibrodysplasia ossificans progressiva. In: Neuromuscular Disorders: Clinical and Molecular Genetics, Alan Emery, Editor. John Wiley and Sons, New York. pp.289-321.
  3. Kaplan, F.S., A.B. Shafritz, and E.M. Shore (1998). Fibrodysplasia ossificans progressiva and the candidate gene approach: A role for bone morphogenetic proteins? In: Skeletal Reconstruction and Bioimplantation, T. Sam Lindholm, Editor. Springer, New York. pp.235-240.
  4. Kaplan, F.S. and E.M. Shore (1999). Illustrative disorders of ectopic skeletal morphogenesis: A childhood parallax for studies in gravitational and space biology. Gravitational and Space Biology Bulletin 12(2) pp. 27-38.
  5. Kaplan, F.S., E.M. Shore, and M.P. Whyte (1999). Fibrodysplasia (myositis) ossificans progressiva. In: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, Fourth Edition. M.J. Favus, Editor. Lippincott, Philadelphia. pp.435-437.
  6. Kaplan, F.S., E.M. Shore, and J.M. Connor (1999) Fibrodysplasia ossificans progressiva. In: Proceedings of the Portland Bone Symposium. Chapter 4. J.O. Hollinger, Editor. Oregon Health Sciences University Press, Portland, OR. pp. 67-89.
  7. Shore, E.M., D.M. Glaser, F.H. Gannon (2000). Osteogenic induction in hereditary disorders of heterotopic ossification. Clin. Ortho. Rel. Res. 374, 303-316.
  8. Luyten, F.P., F.S. Kaplan, and E.M. Shore (2000). Clinical disorders associated with bone morphogenetic proteins. In: Skeletal Growth Factors. E. Canalis, Editor. Lippincott, Philadelphia. pp. 323-334.
  9. Shore, E.M., J.G. Rogers, R. Smith, F.H. Gannon, M. Delatycki, J.A. Urtizberea, J. Triffit, M. LeMerrer, and F.S. Kaplan (2000). Fibrodysplasia ossificans progressiva. In: The Genetic Aspects of Osteoporosis and Metabolic Bone Disease. Michael J. Econs, Editor. Humana Press, Totowa, NJ. pp. 211-236.
  10. Kaplan, F.S. and E.M. Shore (2000). Fibrodysplasia ossificans progressiva and progressive osseous heteroplasia: Hereditary disorders of heterotopic ossification. Osteological Bulletin 5(2), 37-42.
  11. Alman, B., L. Fitzpatrick, E. Shore, B.R. Gomberg, and J.S. Khurana (2000). Bone structure and function: morphology, embryology and bone biology. In: A Compendium of Skeletal Pathology. J.S. Khurana, L. Fitzparick, B. Alman, S.V. Kattapuram, S.S. Gill, G.A. Raj, Editors. United Pathologists Press, USA. pp. 1-31.
  12. Shore, E.M., F.S. Kaplan, and J.S. Khurana (2000). Inherited and dysplastic conditions of the skeleton. In: A Compendium of Skeletal Pathology. J.S. Khurana, L. Fitzparick, B. Alman, S.V. Kattapuram, S.S. Gill, G.A. Raj, Editors. United Pathologists Press, USA. pp. 135-140.
  13. Kaplan, F.S. and E.M. Shore (2000). Progressive osseous heteroplasia: a perspective. J. Bone Min. Res. 15, 2084-2094.
  14. Kaplan, F.S., D.L. Glaser, E.M. Shore, D. Mitchell, S. Emerson, and the FOP Clinical Consortium (2001). Medical management of fibrodysplasia ossificans progressiva: Current treatment considerations. Clin. Proc. Third Intl. Symp. FOP 1(1):1-52.
  15. Cristofalo, V.J., Pignolo, R.J., and Allen, R.G. 2001. Cell Aging In Vitro. In: The Encyclopedia of Aging, third edition. (Maddox, G., Ed.) Springer Publishing Company. pp.172-175.
  16. Cristofalo, V.J., Pignolo, R.J., and Allen, R.G. 2001. Cell Aging Relationship Between In Vitro and In Vivo Models. In: The Encyclopedia of Aging, third edition. (Maddox, G., Ed.) Springer Publishing Company. pp.175-178.
  17. Cristofalo, V.J., Pignolo, R.J., and Allen, R.G. 2001. Senescence and Transformation. In: The Encyclopedia of Aging, third edition. (Maddox, G., Ed.) Springer Publishing Company. pp.904-907.
  18. Mohler ER 3rd, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation 20: 1522-1528, 2001
  19. Kaplan, F.S., E.M. Shore, and J.M. Connor (2002). Fibrodysplasia (myositis) ossificans progressiva. In: Connective Tissue and Its Heritable Disorders: Molecular, Genetic, and Medical Aspects. Second Edition. B. Steinmann and P. Royce, Editors. Wiley-Liss, New York. Chapter 21, pp. 827-840.
  20. Kaplan, F.S., J. Ahn, and E.M. Shore (2002). Fibrodysplasia ossificans progressiva: Evolving insights from a rare disease. In: The Growth Plate Conference. I.M. Shapiro, B. Boyan, and H. C. Anderson, Editors. IOS Press, Washington DC.
  21. Kaplan, F.S., J. Ahn, L. Serrano de la Pena, D.L. Glaser, E.M. Shore (2003). Fibrodysplasia Ossificans Progressiva: Deciphering the Molecular Pathways of Ectopic Skeletogenesis. In: Molecular Biology in Orthopaedics. AAOS Press. in press.
  22. Kaplan, F.S., D.L. Glaser, N. Hebela, E.M. Shore (2003). Heterotopic Ossification. J Am Acad Orthop Surg. in press.
  23. Kaplan, F.S., Glaser, G. L. and E.M. Shore (2003). Fibrodysplasia (myositis) ossificans progressiva. In: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, Fifth Edition. M.J. Favus, Editor. Accepted.
  24. Pignolo, R.J. and Forciea, M.A. 2004. Biology of Aging. In: Geriatric Secrets, third edition. (Forciea, M.A., Lavizzo-Mourey, R., Raziano, D., and Schwab, E.P., Eds.) Hanley & Belfus. In Press.
  25. Pignolo, R.J., Pazianas, M. and Schwab, E.P. 2004. Osteoporosis. In: Geriatric Secrets, third edition. (Forciea, M.A., Lavizzo-Mourey, R., Raziano, D., and Schwab, E.P., Eds.) Hanley & Belfus. In Press.

Letters to the Editor:

  1. 1. Xu, M., E.M. Shore, and F.S. Kaplan (2002). Reported noggin mutations are PCR errors. Amer. J. Med. Genet. 109, 161.
  2. Shore, E.M., F.S. Kaplan, and M.A. Levine (2002). N. Engl. J. Med. 346, 1670-1671.

Books:

  1. Wagman, R.B., A.L. Kantanie and F.S. Kaplan (1995). What is FOP? Fibrodysplasia Ossificans Progressiva: A Guidebook for Families, First Edition. Medical Editors: F.S. Kaplan and J.M. Connor; Scientific Editors: M.A. Zasloff and E.M. Shore. International FOP Association, Casselberry, FL.
  2. Kaplan, F.S., E.M. Shore, and M.A. Zasloff (1995). Proceedings and Abstracts of the Second International Symposium on Fibrodysplasia Ossificans Progressiva. Medical Media, Philadelphia.
  3. Kaplan, F.S., Wagman, R.B., S.R. Wheeler, and F. Gardner (1997). What is POH? Progressive Osseous Heteroplasia: A Guidebook for Families, First Edition. Medical Editors: F.S. Kaplan and F.H. Gannon; Scientific Editors: E.M. Shore and M.S. Zasloff. Progressive Osseous Heteroplasia Association, Indian Head Park, IL.
  4. Wagman, R.B., A.L. Kantanie and F.S. Kaplan (1997). What is FOP? Fibrodysplasia Ossificans Progressiva: A Guidebook for Families, Second Edition. Medical Editors: F.S. Kaplan and J.M. Connor; Scientific Editors: M.S. Zasloff and E.M. Shore. International FOP Association, Winter Springs, FL.
  5. Kaplan, F.S. and E.M. Shore (2000). Transactions of the Third International Symposium on Fibrodysplasia Ossificans Progressiva. University of Pennsylvania Press, Philadelphia.
  6. Kaplan, F.S., E.M. Shore, R.B. Wagman, S. Roth, and F. Gardner (2002). What is POH? Progressive Osseous Heteroplasia: A Guidebook for Families, Second Edition. Scientific and Medical Editors: E.M. Shore, R. B. Wagman, and F.S. Kaplan.